Vbionic Spółka z Ograniczoną Odpowiedzialnością (KRS 0000641322, NIP 7811934007) is a Polish company, headquartered in Poznań, Wielkopolskie voivodeship. VBIONIC operates in: Manufacture of medical and dental instruments and supplies (PKD 32.50.Z). Industry: Other manufacturing. The company has been listed in the National Court Register since October 11, 2016. VBIONIC's most recently reported net revenue was 629.0 K PLN for 2024.
Negative equity
Negative equity in 6 of 7 available reporting years.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Vbionic
Identity
- Name
- Vbionic Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- October 11, 2016
- Registry status as of
- December 10, 2025
- Latest entry
- December 9, 2025
- Founding act
- 09.10.2016 R.
Articles of association history (3)
- October 9, 2016: 09.10.2016 R.
- October 27, 2016: 27.10.2016, REPERTORIUM A 2850/2016, NOTARIUSZ NATALIA NIECEWICZ, KANCELARIA NOTARIALNA W POZNANIU, UL. ŚW. WOJCIECH 10/4, PRZYJĘTY NOWY TEKST JEDNOLITY UMOWY SPÓŁKI
- December 9, 2024: 09.12.2024R., REP. A NR 12.928/2024, NOTARIUSZ MIKOŁAJ SIENNICKI, KANCELARIA NOTARIALNA W POZNANIU, UL. WINOGRADY 67, 61-659 POZNAŃ, ZMIENIONO: § 7 UST. 1, WSTĘP W § 7 UST. 6, § 19 UST. 1, DODANO: § 7 UST. 7.
Activities
Main activity
32.50.ZManufacture of medical and dental instruments and supplies
Other activities
Address and contact
- Address
- UL. MAŁOPOLSKA, 2A, 60-616, POZNAŃ, POLSKA
- Voivodeship
- WIELKOPOLSKIE
- District
- POZNAŃ
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- Not disclosed in the registry
- Coordinates
- 52.4079, 16.9335approx.
Risk and payment profile - Vbionic
Credibility rating
15.2 / 100
Very poor credibility
Insolvency risk
High
Significant formal threat
Closure risk
32
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
3
3/10 yrs
Board changes
1
1/10 yrs
PKD changes
0
0/10 yrs
Name changes
0
0/10 yrs
Data from 10 years of registry activity.
Credibility history
Payment reliability score from 2018–2024
Current: E (15/100)
Trend: deteriorating (-3.9 pts/year)
Bardzo słaba wiarygodność płatnicza – współpraca handlowa wiąże się z wysokim ryzykiem braku zapłaty.
Trade credit limit history
Standard limit from 2018–2024
Current: 51.1 K PLN
Safe: 7.1 K PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Vbionic
Founded
October 11, 2016
9 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
POZNAŃ
WIELKOPOLSKIE
Primary PKD
32.50.Z
Manufacture of medical and dental instruments and supplies
Share capital
49.4 K PLN
834 shares total
Shareholders
1
shareholder
Board
2 people
Filed years
7 years
2018–2024 · profitable: 0/7
Registry entries
21
latest: December 9, 2025
Risk signals
Revenue
629.0 K PLN
2024
Net profit
-2.2 M PLN
2024
Assets
4.2 M PLN
2024
Equity
-4.9 M PLN
2024
EBITDA
-1.1 M PLN
2024
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Vbionic.
No ratings
Related articles
News
Mennica Polska 2026: Q1 revenue +80% YoY (PLN 726.7 m), 838 kg of investment gold (+38%), Bulwary Praskie 95% sold, PLN 1.5 per share dividend
Warsaw-based Mennica Polska S.A. (KRS 0000019196), the only Polish producer of investment-gold bars with three independent business legs (minting, the City Card transit ticket, and the Bulwary Praskie real-estate developer), posted Q1 2026 revenue of PLN 726.7 m (+80% YoY vs PLN 402.9 m) and EBITDA of PLN 56.4 m (+28%). Investment-gold sales: 838 kg (+38% by weight YoY). 2025 closed with EBITDA of around PLN 160 m (+29%) and net profit of around PLN 500 m (a significant part from the developer segment). Bulwary Praskie: 747 apartments with occupancy permits, 95% sold or reserved. Recommended dividend: PLN 1.5 per share (PLN 76.5 m).
Explainer
Mercator Medical in 2026: a Kraków-based medical-glove producer with plants in Thailand, an mWIG40 issuer after the COVID meme-stock cycle
Mercator Medical S.A. (KRS 0000036244), headquartered at ul. Modrzejewskiej 30 in Kraków, is a Polish producer and distributor of single-use medical gloves (nitrile and latex) and other disposables. The company controls the full value chain: plants in Thailand (Mercator Medical Thailand) plus Polish and international distribution. In 2020 the share price exploded on pandemic demand (from PLN 10 to over PLN 800), followed by cautious normalisation. Listed on the WSE since 2013. A three-member management board, a five-member supervisory board.
